Compare FABC & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FABC | IRIX |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 15.0M |
| IPO Year | 1999 | 1996 |
| Metric | FABC | IRIX |
|---|---|---|
| Price | $2.29 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 118.2K | 45.1K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | N/A | ★ N/A |
| Revenue | $4,579,745.00 | ★ $41,593,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.10 | $0.61 |
| 52 Week High | $4.57 | $1.65 |
| Indicator | FABC | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.71 | 34.07 |
| Support Level | $2.10 | $0.61 |
| Resistance Level | $3.01 | $0.98 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 44.74 | 22.54 |
Fabric.AI Inc is an infrastructure company building a suite of fabless semiconductor technologies to power AI factories - smart data centers optimized for producing intelligence at scale. The company's innovations include MicroLED-based optical interconnects and other system-critical technologies that enable faster, more efficient, and more scalable AI workloads. Its mission is to transform data centers into unified production systems for artificial intelligence.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.